AFMD - Affimed gets FDA fast track status for AFM24 for EGFR lung cancer May, 29 2024 10:25 AM Affimed N.V. 2024-05-29 10:25:06 ET More on Affimed Affimed N.V. (AFMD) Q4 2023 Earnings Call Transcript Affimed falls on 1-for-10 reverse stock split Seeking Alpha’s Quant Rating on Affimed Historical earnings data for Affimed Financial information for Affimed For further details see: Affimed gets FDA fast track status for AFM24 for EGFR lung cancer